Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
EV to Sales HistoryFair Value
Percentile Rank79
3Y CAGR-28.2%
5Y CAGR-12.8%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-28.2%/yr
vs +62.5%/yr prior
5Y CAGR
-12.8%/yr
Recent deceleration
Acceleration
-90.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
20225.59-
20210.00-
20200.00-100.0%
201915.13+121.6%
20186.83-38.4%
201711.09+521.3%
20161.79-17.8%
20152.17-2.2%
20142.22-26.8%
20133.03-